Skip to main content

Table 1 Demographics and clinical data of patients with ankylosing spondylitis and healthy control subjects

From: Aberrant expression of interleukin-23-regulated miRNAs in T cells from patients with ankylosing spondylitis

  Patients with AS (n = 24) Healthy control subjects (n = 16) P value
Age (years) 39.5 (33.0–57.8) 39.0 (33.5–43.5) 0.313
Sex (M:F) 12:4 12:4 > 0.999
HLA-B27+ 24 (100%)  
C-reactive protein (mg/dl) 0.24 (0.08–1.24)  
Medication
 NSAID 23 (95.8%)  
 Salazopyrine 24 (100%)  
 Anti-TNF therapy 14 (58.3%)  
  1. Abbreviations: AS Ankylosing spondylitis, HLA Human leukocyte antigen, Not determined, NSAID Nonsteroidal anti-inflammatory drugs, TNF Tumor necrosis factor